Baines Sarah L, Howden Benjamin P, Heffernan Helen, Stinear Timothy P, Carter Glen P, Seemann Torsten, Kwong Jason C, Ritchie Stephen R, Williamson Deborah A
Doherty Applied Microbial Genomics, Department of Microbiology & Immunology, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Australia Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Australia.
Doherty Applied Microbial Genomics, Department of Microbiology & Immunology, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Australia Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Australia Infectious Diseases Department, Austin Health, Melbourne, Australia.
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2359-65. doi: 10.1128/AAC.03020-15. Print 2016 Apr.
The prevalence of fusidic acid (FA) resistance amongStaphylococcus aureusstrains in New Zealand (NZ) is among the highest reported globally, with a recent study describing a resistance rate of approximately 28%. Three FA-resistantS. aureusclones (ST5 MRSA, ST1 MSSA, and ST1 MRSA) have emerged over the past decade and now predominate in NZ, and in all three clones FA resistance is mediated by thefusCgene. In particular, ST5 MRSA has rapidly become the dominant MRSA clone in NZ, although the origin of FA-resistant ST5 MRSA has not been explored, and the genetic context offusCin FA-resistant NZ isolates is unknown. To better understand the rapid emergence of FA-resistantS. aureus, we used population-based comparative genomics to characterize a collection of FA-resistant and FA-susceptible isolates from NZ. FA-resistant NZ ST5 MRSA displayed minimal genetic diversity and represented a phylogenetically distinct clade within a global population model of clonal complex 5 (CC5)S. aureus In all lineages,fusCwas invariably located within staphylococcal cassette chromosome (SCC) elements, suggesting that SCC-mediated horizontal transfer is the primary mechanism offusCdissemination. The genotypic association offusCwithmecAhas important implications for the emergence of MRSA clones in populations with high usage of fusidic acid. In addition, we found thatfusCwas colocated with a recently described virulence factor (tirS) in dominant NZS. aureusclones, suggesting a fitness advantage. This study points to the likely molecular mechanisms responsible for the successful emergence and spread of FA-resistantS. aureus.
新西兰(NZ)金黄色葡萄球菌菌株中夫西地酸(FA)耐药性的流行率在全球报告中处于最高水平,最近一项研究描述的耐药率约为28%。在过去十年中出现了三种耐FA的金黄色葡萄球菌克隆(ST5 MRSA、ST1 MSSA和ST1 MRSA),现在在新西兰占主导地位,并且在所有这三种克隆中,FA耐药性由fusC基因介导。特别是,ST5 MRSA已迅速成为新西兰主要的MRSA克隆,尽管耐FA的ST5 MRSA的起源尚未探究,并且耐FA的新西兰分离株中fusC的遗传背景未知。为了更好地理解耐FA金黄色葡萄球菌的迅速出现,我们使用基于群体的比较基因组学来表征一组来自新西兰的耐FA和对FA敏感的分离株。耐FA的新西兰ST5 MRSA显示出最小的遗传多样性,并且在克隆复合体5(CC5)金黄色葡萄球菌的全球群体模型中代表一个系统发育上不同的进化枝。在所有谱系中,fusC始终位于葡萄球菌盒式染色体(SCC)元件内,这表明SCC介导的水平转移是fusC传播的主要机制。fusC与mecA的基因型关联对于在夫西地酸高使用人群中MRSA克隆的出现具有重要意义。此外,我们发现fusC与优势新西兰金黄色葡萄球菌克隆中最近描述的一种毒力因子(tirS)共定位,这表明具有适应性优势。这项研究指出了耐FA金黄色葡萄球菌成功出现和传播的可能分子机制。